时空单细胞分析解码了细胞动态,这些动态是结直肠癌免疫治疗的不同反应的基础
Yuqing Chen1, Dongfang Wang1, Yingjie Li2
1Biomedical Pioneering Innovative Center (BIOPIC) and School of Life Sciences, Peking University, Beijing 100871, China.
Cancer cell
|July 9, 2024
概括
这项研究绘制了在结直肠癌 (CRC) 中PD-1阻塞期间免疫细胞的变化. 较高水平的特异性T细胞和MHC II特征预测了对免疫治疗的更好的治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 免疫检查点阻塞 (ICB) 在结直肠癌 (CRC) 的有效性需要了解治疗反应动态.
- 阻断PD-1是一种关键的免疫治疗策略,用于治疗各种癌症,包括CRC.
研究的目的:
- 分析PD-1阻塞治疗期间CRC患者局部和全身免疫的演变.
- 识别与治疗反应相关的细胞程序和免疫特征.
主要方法:
- 从经历PD-1封锁的22名CRC患者的顺序样本的单细胞分析.
- 绘制局部瘤免疫和全身免疫变化的图谱.
- 对T细胞表型 (耗尽的T细胞,瘤反应性T细胞) 和主要组织相容性复合体 (MHC) II特征的分析.
主要成果:
- 瘤中的协调细胞程序与治疗反应相关.
- 耗尽的T (Tex) 细胞和瘤反应性CD8+ T (Ttr-like) 细胞与治疗疗效有关.
- 瘤中较少耗尽的Ttr样细胞和循环中的CD8+T细胞中较高的基线MHC II特征预测了更好的结果.
结论:
- 阻断PD-1诱导了CRC瘤和系统性免疫力中的动态变化.
- 特定的T细胞种群和MHC II表达是预测CRC中PD-1阻塞反应的潜在生物标志物.
- 了解这些时空细胞动态可以指导未来的免疫疗法策略.
更多相关视频
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
17.1K
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
7.4K
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...